Delivery Order SPE2DX22D0010-SPE2D826FEZ03
Award Date 4/27/26
Potential Completion Date 4/28/26
Potential Value $2.4K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Medical Supply Chain issued a $1,198.91 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for methamphetamine HCl tablets 5mg, with an ultimate completion date of February 26, 2026.</p> <p>Place of performance is Conshohocken, PA 19428. The order is priced on a firm fixed-price basis and carries no set-aside designation.</p>
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,578.50 on August 4, 2025, for the supply of Methamphetamine HCL tablets (5mg). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Methamphetamine HCL tablets (5mg) with a ceiling value of $15,931.83. This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 5, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open...
- The Defense Logistics Agency Medical Supply Chain issued a $2,056.96 delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for amphetamine mix tablets 30mg, with an ultimate completion date of March 10, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was issued under no set-aside. The order is called against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency Medical Supply Chain issued a $146,602.46 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, with ultimate completion on April 10, 2026, under a firm fixed-price contract for pharmaceutical supply. Place of performance is Conshohocken, PA. The order was issued under no set-aside on a competitive basis. Amerisourcebergen Drug Corp operates as a division of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The...
- The Defense Logistics Agency Medical Supply Chain issued a $4,983.35 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for amphetamine mix (AD) extended-release capsules, 20 mg, with an ultimate completion date of March 5, 2026. The order is firm fixed price and carries no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,989.00. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,017.90 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for pharmaceutical supply to a DLA facility. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of April 21, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal...
- The Defense Logistics Agency Medical Supply Chain issued a $10,447.93 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, with an ultimate completion date of April 7, 2026, for pharmaceutical supply under a firm fixed-price structure. Place of performance is Conshohocken, PA. The order was issued on a non-set-aside basis and represents a call against the parent Indefinite Delivery Contract held with the DLA Troop Support Medical, which supports global pharmaceutical and medical...
- The Defense Logistics Agency's Medical Supply Chain issued a $4,139.36 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for pharmaceutical supplies with an ultimate completion date of April 28, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FEZ03Delivery Order
The Defense Logistics Agency's Medical Supply Chain issued a $2,397.82 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for methamphetamine HCl 5 mg tablets, with completion by April 28, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as the execution entity for DLA pharmaceutical distribution, holding a single-award indefinite delivery contract with DLA Troop Support Medical valued at $4.999 million through December 2036 under the Pharmaceutical Prime Vendor Global Program Generation V.
Generated 7/26/26, 9:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/26/26 |